Catalyst Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Catalyst Pharmaceuticals, Inc.

Jun-30	Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses GlobeNewswire
May-11	Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results GlobeNewswire
May-07	Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast GlobeNewswire
May-07	Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Hetero Labs Ltd. GlobeNewswire
Apr-28	Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026 GlobeNewswire
Mar-06	Catalyst Pharmaceuticals to Showcase Real-World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference GlobeNewswire
Feb-25	Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance GlobeNewswire
Feb-24	Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference GlobeNewswire
Feb-11	Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 GlobeNewswire
Jan-08	Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies GlobeNewswire
Jan-05	The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) GlobeNewswire
Dec-15	Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Nov-24	Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference GlobeNewswire
Nov-19	Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500 GlobeNewswire
Nov-18	Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference GlobeNewswire
Nov-05	Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire
Nov-04	Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work GlobeNewswire
Nov-03	Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference GlobeNewswire
Oct-22	Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 GlobeNewswire
Oct-09	Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences GlobeNewswire
Oct-01	Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program GlobeNewswire
Aug-28	Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-26	UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals GlobeNewswire
Aug-25	Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals GlobeNewswire
Aug-06	Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update GlobeNewswire
Aug-06	Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC) GlobeNewswire
Aug-04	Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors GlobeNewswire
Jul-22	Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 GlobeNewswire
Jun-02	Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer GlobeNewswire
May-07	Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Catalyst Pharmaceuticals, Inc.

Recent Articles by Catalyst Pharmaceuticals, Inc.

Upgrade your Finviz experience